| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.9 | $0-$5k | 0.00 |
Summary
A vulnerability was found in OSQA 3b. It has been rated as problematic. This vulnerability affects unknown code. Performing a manipulation results in cross site scripting. This vulnerability is cataloged as CVE-2012-1782. It is possible to initiate the attack remotely. Furthermore, there is an exploit available.
Details
A vulnerability was found in OSQA 3b. It has been classified as problematic. This affects an unknown function. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Multiple cross-site scripting (XSS) vulnerabilities in questions/ask in OSQA 3b allow remote attackers to inject arbitrary web script or HTML via the (1) url bar or (2) picture bar.
The weakness was shared 03/19/2012 by Ucha Gobejishvili with Vulnerability Research Laboratory (Website). It is possible to read the advisory at vulnerability-lab.com. This vulnerability is uniquely identified as CVE-2012-1782 since 03/19/2012. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Technical details are unknown but a public exploit is available. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
The exploit is shared for download at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at Exploit-DB (36886) and SecurityFocus (BID 52184†). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.9
VulDB Base Score: 4.3
VulDB Temp Score: 3.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/27/2012 🔍03/19/2012 🔍
03/19/2012 🔍
03/19/2012 🔍
03/23/2015 🔍
02/09/2025 🔍
Sources
Advisory: vulnerability-lab.comResearcher: Ucha Gobejishvili
Organization: Vulnerability Research Laboratory
Status: Not defined
CVE: CVE-2012-1782 (🔍)
GCVE (CVE): GCVE-0-2012-1782
GCVE (VulDB): GCVE-100-60459
SecurityFocus: 52184 - OSQA's CMS Multiple HTML Injection Vulnerabilities
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 03/23/2015 16:50Updated: 02/09/2025 21:37
Changes: 03/23/2015 16:50 (45), 02/16/2019 14:33 (5), 02/09/2025 21:37 (27)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.